Clinical Trials Sponsored by Sanwa Kagaku Kenkyusho Co., Ltd.

Total 34 results

Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

Phase 3 Study of SK-1403

Secondary Hyperparathyroidism

Japan
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

SK-1403 Long-term Treatment Study; Long-term Study in Patients With Secondary Hyperparathyroidism Receiving Hemodialysis

Secondary Hyperparathyroidism

Japan
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

A Study of SK-1405 in Hemodialysis Patients With Uremic Pruritus

Uremic Pruritus in Hemodialysis Patients

Japan
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

Trial of SK-1404 for Nocturia Due to Nocturnal Polyuria in Japanese Subjects

Nocturia Due to Nocturnal Polyuria

Japan
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion

Macular Degeneration | Macular Edema | Branch Retinal Vein Occlusion

Japan
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

Effects of Miglitol on Daily Plasma Glucose in type2 Diabetes Treated With Insulin

Type 2 Diabetes Mellitus

Japan
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

A Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-SK-1405

Pruritus

United Kingdom
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

A Study of the Safety and Efficacy of SK-0503 for Diabetic Macular Edema

Diabetic Macular Edema

Japan
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide

Type 2 Diabetes Mellitus

Japan
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin Treatment

Type 2 Diabetes Mellitus

Japan
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin Treatment

Type 1 Diabetes Mellitus

Japan
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

Dose Adjustment Trial of SK-1403 in Hemodialysis Patients With Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

Japan
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

Bioavailability of [14C]-SK-1404 ADME & IV Microtracer Study

Nocturia

United Kingdom
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

A Study to Investigate the Receptor Occupancy of SK-1405 in Healthy, Caucasian, Male Subjects

Pruritus

United Kingdom
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

A Study to Evaluate Efficacy and Safety of Methacholine Chloride Challenge Test in Diagnosis of Adult Asthma

Asthma

Japan
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

Open Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide

Type 2 Diabetes Mellitus

Japan
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

Double-Blind Study of Miglitol in Japanese With type2 Diabetes

Type 2 Diabetes Mellitus

Japan
Sanwa Kagaku Kenkyusho Co., Ltd.
Fuji Yakuhin Co., Ltd.

Completed

Effect of Topiroxostat on Urinary Albumin Excretion Early Stage Diabetic Nephropathy and Hyperuricemia With or Without Gout (UPWARD)

Diabetic Nephropathy

Japan
Nippon Kayaku Co., Ltd.

Completed

Safety and Efficacy on Deoxyspergualin (NKT-01) in Patients With Lupus Nephritis

Lupus Nephritis

Germany, Czech Republic
Nippon Kayaku Co., Ltd.

Completed

A Study of NK012 in Patients With Advanced, Metastatic Triple Negative Breast Cancer

Triple Negative Breast Cancer

United States
Nippon Kayaku Co., Ltd.

Completed

Study of NK012 and Carboplatin in Solid Tumors With Dose Expansion in Triple Negative Breast Cancer

Advanced Solid Tumors | Metastatic Triple Negative Breast Cancer

United States
Nippon Kayaku Co., Ltd.

Terminated

Efficacy and Safety of Deoxyspergualin in Renal Transplant Patient With Chronic Rejection

Chronic Rejection

Japan
Nippon Kayaku Co., Ltd.

Completed

A Study of NK012 in Patients With Relapsed Small Cell Lung Cancer

Small Cell Lung Cancer

United States
Nippon Kayaku Co., Ltd.

Completed

A Phase III Study of NK105 in Patients With Breast Cancer

Breast Cancer Nos Metastatic Recurrent

Japan
Nippon Kayaku Co., Ltd.

Completed

Study of NK012 in Patients With Refractory Solid Tumors

Cancer

United States
Nippon Kayaku Co., Ltd.

Completed

Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis

Wegener's Granulomatosis

United Kingdom, Germany, Sweden, Czech Republic, Denmark, Netherlands
Nippon Kayaku Co., Ltd.

Completed

Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer

Metastatic Colorectal Cancer | Advanced Solid Tumors

United States
Celltrion
Nippon Kayaku Co., Ltd.

Completed

Efficacy and Safety Evaluating Study of CT-P6 in Her2 Positive Early Breast Cancer

HER2-positive Carcinoma of Breast

Italy, South Africa, Mexico, Japan, Taiwan, Russian Federation, Philippines, Hungary, Romania, Spain, Bosnia and Herzegovina, India, Peru, Ukraine, Latvia, Argentina, Georgia, Belarus, Chile, France, Poland, Portugal
Hiroshima University
CHUGOKU KAYAKU CO., LTD.

Completed

Comparison of Absorbability Between Calcium Tablet and Calcium Ion Water

Healthy

Japan
Nippon Kayaku Co., Ltd.
Handok Inc.

Terminated

Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC)

Bladder Cancer

Japan, Korea, Republic of
Nippon Kayaku Co., Ltd.
Shionogi; AEterna Zentaris

Completed

Clinical Pharmacological Study of GnRH Antagonist, Cetrorelix for Healthy Female Volunteer

Premenopause

Japan
Pfizer
Parexel; SACT INTERNATIONAL Co., LTD.; Acronet; Bellsystem24 , Inc.; Mitsubishi Kagaku... and other collaborators

Completed

Dalacin-T Gel Post Approval Study

Acne Vulgaris
Universiti Putra Malaysia
Kagawa University; Matsutani Chemical Industry Co., Ltd.

Completed

The Effect of D-allulose on the Glycemic Changes in Patients With Type 2 Diabetes Mellitus During Ramadan Fasting

Glucose, High Blood

Malaysia

Clinical Trials Sponsored by Sanwa Kagaku Kenkyusho Co., Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Morocco

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations